A case of septicemia caused by vancomycin-resistant Pediococcus acidilactici is discussed. This appears to be the first reported case of septicemia caused by this organism. The characteristics and antimicrobial susceptibilities of this organism are described.
109/liter. A bone marrow aspirate was hypercellular, with over 90% of nucleated cells being poorly differentiated blasts. The findings were consistent with acute myeloblastic leukemia (type Ml in the FAB classification).
Intravenous empiric therapy with vancomycin (500 mg four times a day) and ceftazidime (1 g three times a day) was commenced. He was given oral acyclovir (1 g daily) in divided doses, allopurinol (300 mg daily), chlorhexidine sachets, and nystatin lozenges.
On day 3 after admission, intravenous metronidazole (500 mg three times a day) was added to the treatment, since the patient developed a tender swelling at the left angle of the jaw.
By day 6, fever persisted, with a rise in the absolute blast cell count from 28 To confirm an organism as a Pediococcus sp., a Gram stain is useful. Coccoid cellular arrangements in clusters and tetrads are consistently observed. Gas is not produced from glucose, a reaction with group D streptococcal antisera is usually seen, and the bile-esculin reaction is positive. In addition, there is a negative test reaction for pyrrolidonylarylamidase activity and a positive reaction for leucine aminopeptidase. Growth is variable in 6.5% NaCI, and the organism grows at 45°C. The lack of acidification of maltose and a negative Voges-Proskauer test result confirm this organism to be P. acidilactici and not another member of the Pediococcus genus. In addition, it would have been possible to identify this organism as an enterococcus because of its reaction with group D antisera, bile-esculin positivity, and growth in 6.5% NaCl. The negative test for pyrrolidonylarylamidase activity and lack of acidification of mannitol exclude this possibility.
There appears to be little doubt that pediococci are rare clinical isolates and that these organisms are opportunistic pathogens. Nevertheless, it is possible that infections with these organisms have been missed in the past. With the widespread use of vancomycin and increasing reports of resistance, coupled with the value of vancomycin resistance as a screening test for these unusual organisms, routine susceptibility testing of all gram-positive isolates against vancomycin is warranted. This report underlines the importance of the accurate identification of organisms found to be vancomycin resistant.
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